Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Serum triglyceride levels are not linked to prostate cancer risk.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain natural compounds called terpenes may help prevent prostate cancer.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.